Skip to ContentSkip to Navigation
Research Department of Gastroenterology and Hepatology
University Medical Center Groningen

Recent Theses

Title Promotor(s) Co-promotor(s)

2023

Defo Kong Cause and consequences of enhanced LGR5 expression in human liver cirrhosis Prof. dr. K.N. Faber, Prof. dr. V.E. de Meijer Dr. J. Blokzijl
Iris Schmidt Quantitative fluorescence molecular endoscopy - a multidimensional approach for cancer detection Prof. dr. W.B. Nagengast Dr. D.J. Robinson, Dr. D. Gorpas
Sandra Serna Salas Studies on the role of adrenergic antogonists in the treatment of metabolic-dysfunction associated fatty liver disease and liver fibrosis Prof. dr. A.J. Moshage, Prof. dr. K.N. Faber
Matthijs Linssen Fluorescently labelled monoclonal antibodies for real-time molecular imaging: Pharmaceutical develpment of near-infrared tracers and their application in clinical settings Prof. dr. W.B. Nagengast, Prof. dr. G.M. van Dam, prof. dr. G. Dijkstra Dr. A. Jorritsma-Smit
Arno Bourgonje Biomarker signatures in pathophysiology and therapeutic interventions in inflammatory bowel diseases: a multimodal approach Prof. dr. G. Dijkstra, Prof. dr. K.N. Faber, Prof. dr. H. van Goor, Prof. dr. R.K. Weersma

2022

Zongmei Wu Metabolic Dysfunction-associated Fatty Liver Disease: Mechanisms and targets for intervention Prof. dr. A.J. Moshage, Prof. dr. G. van Dijk
Xiaojuan Zhao Developments in molecular and advanced endoscopic imaging in esophageal cancer Prof. dr. W.B. Nagengast, Prof. dr. M.A.T.M. van Vugt Dr. R.S.N. Fehrmann
Guido Trentadue Organ-specific interventions in intestinal transplantation Prof. dr. G. Dijkstra, Prof. Dr. K.N. Faber Dr. J.W. Haveman, Dr. G. Kats-Ugurlu
Eline Wouters-van den Berg Metabolic associated fatty liver disease: prevalence and determinants Prof. dr. R.K. Weersma, Dr. R.P.F. Dullaart, Prof. dr. K.N. Faber Dr. J. Blokzijl
Raphael Fagundes Rosa Microenvironmental modulation of the intestinal epithelial barrier Prof. dr. K.N. Faber, Dr. ir. H.J.M. Harmsen, Prof. dr. G. Dijkstra

2021

Shixian Hu Understanding the complexity of inflammatory bowel disease from a multi-omics perspective Prof. dr R.K. Weersma, Prof dr. J. Yang-Fu Dr. A. Vich Vila
Yanni Li Genetic and environmental effects on liver diseases Prof. dr. R.K. Weersma, Dr. E.A.M. Festen Dr. V.E. de Meijer
Alejandra Hernandez Villanueva Role of extracellular vesicles in hypoxia-induced hepatic injury in non-alcoholic fatty liver disease Prof. dr. A.J. Moshage, Prof. dr. M Arrese
Werna Uniken Venema Gut mucosal gene expression in inflammatory bowel disease. The heterogeneous nature of inflammation Prof. dr. R.K. Weersma Dr. E.A.M. Festen
Fabio Aguilar Mora Targeting mitochondria to prevent diclofenac-induced liver toxicity Prof. dr. A.J. Moshage Prof. dr. K.N. Faber
Jolien Tjalma Molecular flurorescence endoscopy: clinical development and validation within the lower gastrointestinal tract Prof. dr. W.B. Nagengast, Prof. dr. G.A.P. Hospers, Prof. dr. J.H. Kleibeuker
Floris Voskuil Clinical application of near infrared fluorescence imaging in solid cancers: Improving surgical accuracy by lighting up tumors Dr. M.J.H. Witjes, Prof. dr. G.M. van Dam, Prof. dr. W.B. Nagengast
Kim van der Sloot The exposome in development and behaviour of Inflammatory Bowel Disease

Prof. dr. G. Dijkstra, Prof. dr. R.K. Weersma

Dr. B.Z. Alizadeh

Vera Peters Towards dietary assessment and interventions for patients with inflammatory bowel disease Prof. dr. G. Dijkstra Dr. B.Z. Alizadeh, dr. M.J.E. Campmans-Kuijpers
Valerie Collij The gut microbiota and inflammatory bowel disease: From exploration to clinical translation Prof. dr. R.K. Weersma, Prof. dr. J. Yang-Fu Dr. A. Vich Vila

2020

Archie Mposhi Unravelling the molecular mechanisms underlying mitochondrial dysfunction in metabolic diseases Prof. dr. K. N. Faber, Prof. dr. M. G. Rots
Shiva Koets-Shajari Novel strategies targeting hepatic stellate cells to reverse liver fibrosis

Prof. dr. K.N. Faber, Prof. dr. A.J. Moshage

Mengfan Zhang Targetting hepatic stellate cells to prevent or reverse fibrosis

Prof. dr. A.J. Moshage, Prof dr. K.N. Faber

Michiel Voskuil Genomic medicine in inflammatory bowel disease

Prof. dr. R.K. Weersma

Dr. E.A.M. Festen
Turtushikh Damba The role of the gaseous signaling molecule hydrogen sulfide in chroninc liver disease: Special emphasis on non-alcoholic fatty liver disease Prof. dr. A.J. Moshage, Prof. dr. H. van Goor
Steven de Jongh Fluorescence-guided endoscopy and surgery: Clinical applications for optical imaging agents Prof. dr.R.K. Weersma, Prof. dr. G.M. van Dam Prof. dr. W.B. Nagengast
Yana Geng Lipotoxicity in non-alcoholic fatty liver disease: mechanisms and prevention in experimental models

Prof. dr. A.J. Moshage, Prof dr. K.N. Faber

Dr. J. Blokzijl

Natalia Smith Cortínez Novel molecular targets in hepatic stellate cells for the treatment of liver fibrosis Prof. dr. K.N. Faber, Prof. dr. A.J. Moshage
Yingying Cui Epithelial and subeoithelial players in chronic intestinal disease Prof. dr. K.N. Faber, prof. dr. G.Dijkstra
Danial Afsharzadeh Decoding therapeutic roles of adipose tissue-derived stromal cells and their extracellular vesicles in liver disease Prof. dr. K.N. Faber, Prof. dr. M.C. Harmsen, Prof. A. Canbay

2019

Arnau Vich Vila Understanding the gut ecosystem: bugs, drugs & diseases Prof. dr. R. Weersma, Prof. dr. A.P. Zhernakova
Tobias van Haaften Biomarkers, Models and Mechanisms of Intestinal Fibrosis Prof. dr. P Olinga, Prof. dr. G. Dijkstra Dr. M. Boersema
Ali Saeed Disturbed vitamin A metabolism in chronic liver disease and relevance for therapy Prof. dr. K.N. Faber Dr. J. Blokzijl
Julius von Martels Towards novel biomarkers and rational nutritional interventions in Inflammatory Bowel Disease Prof. dr. G. Dijkstra, Prof. dr. P. de Vos, Prof. K.N. Faber Dr. ir. H.J.M. Harmsen
Floris Imhann The gut microbiome in intestinal diseases and the infrastructure to investigate it Prof. dr. R.K. Weersma, Prof. dr. C. Wijmenga

2018

Lieke Spekhorst Clinical and genetic factors associated with disease couse in inflammatory bowel disease Prof. dr. R.K. Weersma, Prof. dr. G. Dijkstra Dr. E.A.M. Festen
Wilson Alfredo Rios Ocampo Cellular stress response during hepatitis C virus infection: a balancing act between viral persistence and host cell survival Prof. dr. A.J. Moshage, Prof. dr. C.A.H.H. Daemen, Prof. dr. K.N. Faber, Prof. M.C. Navas -
Marijn Visschedijk Inflammatory Bowel Disease Prof. dr. R.K. Weersma, Prof. dr. C. Wijmenga Dr. C.C. van Diemen, Dr. E.A.M. Festen

2016

Xueting Bai Therapeutic effects of the traditional medicinal plant Ipomoea stolonifera for the treatment of liver diseases Prof. dr. K.N. Faber, Prof. dr. A.J. Moshage, Prof. dr. G. Shi -

2015

Mehdi Sadaghian Sadabad Interaction between the gut and its microbiota in inflammatory bowel disease Prof. dr. G. Dijkstra, Prof. dr. K.N. Faber Dr. ir. H.J.M. Harmsen

2014

Anouk Regeling Gene-environment interactions in inflammatory bowel disease Prof. dr. K.N. Faber, Prof. dr. G. Dijkstra -
Marjolein H. Tiebosch Antioxidant adaptations inliver fibrogenesis Prof. dr. A.J. Moshage, Prof. dr. K.N. Faber -

2013

Martijn O. Hoeke The role of vitamin A in bile acid synthesis transport and the relevance for cholestatic liver disease Prof. dr. K.N. Faber, Prof. dr. A.J. Moshage
Krzysztof P. Rembacz The functional relationship between peroxisomes, bile acids and lipid rafts in the liver Prof. dr. K.N. Faber, Prof. dr. A.J. Moshage

2012

Golnar Kariman Signal Transduction Pathways in Hepatocyte Cell Death: New Targets for therapy Prof. dr. A.J. Moshage, Prof dr. K.N. Faber

2011

Frans van der Heide Studies on smoking in patients with inflammatory bowel disease and liver transplant reciepients Prof. dr. J.H. Kleibeuker, Prof. dr. K.N. Faber Dr. G. Dijkstra, Dr. E.B. Haagsma
Noortje Festen Shared genetic background of inflammatory diseases of the bowel Prof. dr. C. Wijmenga, Prof. dr. J.H. Kleibeuker Dr. R.K.Weersma
Axel van Steenpaal Function and regulation of the multidrug resistance-associated protein 1 during inflammatory bowel disease and liver regeneration Prof. dr. K.N. Faber, Prof. dr. A.J. Moshage Dr. G. Dijkstra

2010

Lu Zhou Inflammatory Bowel Diseases from Genetics to Immunology Prof. dr. K.N. Faber, Prof. dr. M.P. Peppelenbosch Dr. G. Dijkstra, Dr. R.K.Weersma

2009

Jannes Woudenberg Novel aspects of peroxisome composition and function in the liver Prof. dr. A.J. Moshage Dr. K.N. Faber

2008

Sandra Dunning Resistance of activated stellate cells to cell death in liver fibrosis: mechanisms and targets for intervention Prof. dr. A.J. Moshage Dr. K.N. Faber
Antonella Pellicoro Hepatic peroxisome function in health and disease Prof. dr. P.L.M. Jansen, Dr. K.N. Faber
Hans Blokzijl Functional regulation of transport proteins in gastrointestinal and liver disease Prof. dr. P.L.M. Jansen, Prof. dr. A.J. Moshage Dr. K.N.Faber, Dr. G. Dijkstra
Titia Vrenken Mechanisms and prevention of hepatocyte cell death Prof. dr. A.J. Moshage

2007

Rinse Weersma Genetic susceptibility for inflammatory bowel diseases. Prof. dr. J.H. Kleibeuker, Prof. dr. C. Wijmenga
Robert Verdonk Complications after liver transplantation: A focus on bowel and bile ducts. Prof. dr. J.H. Kleibeuker Dr. E.B. Haagsma, Dr. G. Dijkstra, Dr. R.J. Porte

2006

Laura Conde de la Rosa Mechanisms of oxidative stress-induced cell death in hepatocytes: Targets for protective intervention Prof. dr. A.J. Moshage, Prof. dr. P.L.M. Jansen
Mathilde Jalving Apoptosis pathways in (pre)maligant gastrointestinal tumours: potentials for intervention Prof. dr. J.H. Kleibeuker, Prof. dr. E.G.E. de Vries Dr. S. de Jong, Dr. J.J. Koornstra, Dr. J. Wesseling
Fleur E.M. Rijcken Hereditary nonpolyposis colorectal cancer. Studies on tumor development and preventive stratagies. Prof. dr. H. Hollema, Prof. dr. J.H. Kleibeuker, Prof. dr. A. van der Zee
Liekele E. Oostenbrug Low penetrance susceptibility genes in inflammatory bowel disease Prof. dr. P.L.M. Jansen, Prof. dr. J.H. Kleibeuker Dr. ir. G.J. te Meerman, Dr. H.M. van Dullemen
Jan Jacob Koornstra Apoptosis and colorectal cancer. Studies on pathogenesis and potential therapeutic targets Prof. dr. H. Hollema, Prof. dr. J.H. Kleibeuker, Prof. dr. E.G.E. de Vries Dr. S.de Jong

2005

Jacqueline Plass Function and regulation of the human bile salt export pump Prof.dr. P.L.M. Jansen Dr. K.N.Faber
Mirjam de Jong Identification of genes other than the high-penetrance genes involved in colorectal and/or breast cancer susceptibility Prof. dr. J.H. Kleibeuker, Prof. dr. E.G.E. de Vries dr. G.J. te Meerman, dr. W.T.A. de Graaf

2004

Janneke van der Woude Apoptosis in (pre) malignant lesions in the gastro-intestinal tract Prof. dr. P.L.M. Jansen, Prof. dr. J.H. Kleibeuker Dr. A.J. Moshage
Marieke Schoemaker Apoptotic cell death as a target for the treatment of acute and chronic liver injury Prof. dr. P.L.M. Jansen, Prof. dr. H.J. Haisma Dr. A.J. Moshage, Dr. K. Poelstra
Gerard Dijkstra Inducible nitric oxide synthase in intestinal inflammation Prof. dr. P.L.M. Jansen Dr. A.J. Moshage, Dr. H van Goor

2003

Maran Berends Towards optimal identification of carriers of germline mutations involved in mismatch repair
Laurens van der Waaij The interaction between the mucosal system and the commensal microflora of the colon Prof. dr. P.L.M. Jansen, Prof, dr. F.G.M. Kroese

2002

Leo Meerman The power of purple, protoporphyrins in the liver
Jenny Ros Expression and regulation of ABC transporter genes during liver regeneration Prof. dr. P.L.M. Jansen, Prof. dr. M. Müller

2000

Johan Renes (Patho)physiological function of the multidrug resistance protein MRP1 Prof. dr. P.L.M. Jansen, Prof. dr.E.G.E. de Vries Dr. M. Müller
Guido Hooiveld P-glycoproteins and hepatiobiliary secretion, studies on cloning, function, and expression Prof. dr. D.K.F. Meijer, Prof. dr. P.L.M. Jansen Dr. M. Müller

1999

Thera Vos Regulation of the hepatic expression of iNOS and ABC-transporters

1995

Reint Huizenga Ammonia in human fluids methodology and clinical applications
Ids Klompmaker Clinical Aspects of immunosuppression in liver transplantation

Last modified:28 February 2024 4.43 p.m.